share_log

药明生物(02269.HK)获李革增持20万股普通股股份,价值约238.34万港元

Wuxi Bio (02269.HK) received Li Ge's shareholding of 200,000 ordinary shares, valued at approximately HKD 2.3834 million.

Futu News ·  Jun 21 17:04

According to documents disclosed by the Hong Kong Stock Exchange on June 21, Li Ge increased his shareholding on June 20 at an average price of HKD 11.9171 per share.$WUXI BIO (02269.HK)$He purchased 200,000 ordinary shares with a value of approximately HKD 2.3834 million. After the increase, Li Ge's latest shareholding number is 590 million shares, and his warehouse ratio has increased from 14.21% to 14.22%.

Supplementary information: Box 33: Mr. Zhaohui Zhang and Mr. Xiaozhong Liu continue to be concerted parties in respect of the 590,457,633 shares of the Company.

HKEXAutoNews_DA20240621E00255.png

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment